THERACLION HUGE BREAKOUT OF Accumulation range : Growth stockTHERACLION HUGE BREAKOUT OF Accumulation range .
This technology is the "new Intuitive surgical"
Huge triangle Accumulation ready for growth stock
−0.078 EUR
−3.68 M EUR
1.82 M EUR
32.62 M
About THERACLION
Sector
Industry
CEO
Martin Deterre
Website
Headquarters
Malakoff
Founded
2004
ISIN
FR0010120402
FIGI
BBG006BRBRM8
Théraclion SA develops, manufactures, and markets oncological medical equipment. Its products are marketed under the brands of Sonovein, EchoPulse and EPack. EchoPulse is a device used for non-invasive and outpatient treatment of fibroadenoma of the breast and thyroid nodules. EPack is a single-use disposable patented system used for cooling and coupling functions. The company was founded by François Lacoste and Jérôme Lebon on August 5, 2004 and is headquartered in Malakoff, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALTHE is 0.332 EUR — it has decreased by −2.64% in the past 24 hours. Watch THERACLION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange THERACLION stocks are traded under the ticker ALTHE.
ALTHE stock has fallen by −17.41% compared to the previous week, the month change is a −2.35% fall, over the last year THERACLION has showed a −10.27% decrease.
ALTHE reached its all-time high on May 15, 2014 with the price of 13.351 EUR, and its all-time low was 0.286 EUR and was reached on Aug 14, 2024. View more price dynamics on ALTHE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALTHE stock is 2.71% volatile and has beta coefficient of 0.73. Track THERACLION stock price on the chart and check out the list of the most volatile stocks — is THERACLION there?
Today THERACLION has the market capitalization of 15.30 M, it has decreased by −4.47% over the last week.
Yes, you can track THERACLION financials in yearly and quarterly reports right on TradingView.
ALTHE net income for the last half-year is −2.36 M EUR, while the previous report showed −1.20 M EUR of net income which accounts for −97.11% change. Track more THERACLION financial stats to get the full picture.
No, ALTHE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERACLION EBITDA is −2.90 M EUR, and current EBITDA margin is −161.84%. See more stats in THERACLION financial statements.
Like other stocks, ALTHE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERACLION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THERACLION technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THERACLION stock shows the sell signal. See more of THERACLION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.